| Website | uptakemedical.com |
| @UptakeMedical | |
| Category | BioTech |
| Phone | 949-440-1800 |
| Employees | |
| Founded | 2005 |
| TOTAL | $52.5M |
| FUNDING TOTAL | $52.5M |
| Series B, 7/10 Maverick Capital GBS Ventures ONSET Ventures WRF Capital Arboretum Ventures Affinity Capital Management | $17.5M |
| Series C, 2/12 Crescent Point Maverick Capital ONSET Ventures GBS Ventures WRF Capital Arboretum Ventures Affinity Capital Management | $35M |
Uptake Medical develops innovative medical technologies for the treatment of lung diseases. Its first product, InterVapor™, is the first and only approach to endoscopic lung volume reduction for people with severe emphysema that uses the body’s natural healing process without leaving any foreign materials in the lung. In clinical studies, InterVapor has demonstrated clinically meaningful improvements in breathing function, exercise capacity and quality of life.
